A drug called bumetanide, which is used to treat edema in people, reduced this cellular swelling and resulting cell death in mice. Mice given the drug after an injury were better able to move their ...

Medical device company Nevro has received approval from the US Food and Drug Administration (FDA) and announced a limited ...

Nevro announced today that it received FDA approval for an AI-powered, personalized pain management platform for spinal cord ...

To millions, Christopher Reeve was Superman on- and offscreen. The strikingly handsome 6-foot-4 actor not only played the ...

XoMotion, which is based on other advanced humanoid robotics, is intended to assist physical therapists by helping to lift, ...

Nevro earned FDA approval and began a limited market release of its HFX iQ spinal cord stimulator with HFX AdaptivAI, the company said Sept. 24.

After a spinal cord injury, nearby cells quickly rush to action, forming protective scar tissue around the damaged area to ...

David Julius and Wendy Yue have discovered a natural mechanism that could help reduce scarring after a spinal cord injury.

University of Rochester Medical Center teamed up with Rochester Spinal Association to host the Spinal Cord Injury Health Fair ...

A study on mice demonstrates that engineered immune cell therapy safeguards damaged neurons. Severe spinal cord injuries harm ...

personalized pain management platform powering the HFX iQ spinal cord stimulation (SCS) system. Building on a foundation of ...

Minimally invasive technology would allow for percutaneous placement of a paddle electrodeRenowned pain specialist Dr. Sean Li to present on this ...